- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The Prostate Cancer Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Prostate Cancer Drugs market size is estimated to be worth US$ 6493 million in 2021 and is forecast to a readjusted size of USD 9906.2 million by 2028 with a CAGR of 6.2% during review period. Clinics accounting for % of the Prostate Cancer Drugs global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Hormonal Therapy segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Prostate Cancer Drugs include AbbVie, Astellas Pharma, Astra Zeneca, Johnson & Johnson, and Sanofi, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Prostate Cancer Drugs market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Hormonal Therapy
Chemotherapy
Immunotherapy
Targeted Therapy
Market segment by Application can be divided into
Clinics
Hospitals
Others
The key market players for global Prostate Cancer Drugs market are listed below:
AbbVie
Astellas Pharma
Astra Zeneca
Johnson & Johnson
Sanofi
GlaxoSmithKline
Merck Group
Novartis
Amgen
Bayer HealthCare
Ferring Pharmaceutical
Janssen Pharmaceuticals
Endo Pharmaceuticals
BMS
Takeda Pharmaceuticals
Northwest Biotherapeutics
Teva Pharmaceutical
Boehringer Ingelheim
Foresee Pharmaceuticals
Tokai Pharmaceuticals
Spectrum Pharmaceuticals
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Prostate Cancer Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Prostate Cancer Drugs, with price, sales, revenue and global market share of Prostate Cancer Drugs from 2019 to 2022.
Chapter 3, the Prostate Cancer Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Prostate Cancer Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Prostate Cancer Drugs market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Prostate Cancer Drugs.
Chapter 13, 14, and 15, to describe Prostate Cancer Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Prostate Cancer Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Prostate Cancer Drugs Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Hormonal Therapy
1.2.3 Chemotherapy
1.2.4 Immunotherapy
1.2.5 Targeted Therapy
1.3 Market Analysis by Application
1.3.1 Overview: Global Prostate Cancer Drugs Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Clinics
1.3.3 Hospitals
1.3.4 Others
1.4 Global Prostate Cancer Drugs Market Size & Forecast
1.4.1 Global Prostate Cancer Drugs Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Prostate Cancer Drugs Sales in Volume (2017-2028)
1.4.3 Global Prostate Cancer Drugs Price (2017-2028)
1.5 Global Prostate Cancer Drugs Production Capacity Analysis
1.5.1 Global Prostate Cancer Drugs Total Production Capacity (2017-2028)
1.5.2 Global Prostate Cancer Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Prostate Cancer Drugs Market Drivers
1.6.2 Prostate Cancer Drugs Market Restraints
1.6.3 Prostate Cancer Drugs Trends Analysis
2 Manufacturers Profiles
2.1 AbbVie
2.1.1 AbbVie Details
2.1.2 AbbVie Major Business
2.1.3 AbbVie Prostate Cancer Drugs Product and Services
2.1.4 AbbVie Prostate Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Astellas Pharma
2.2.1 Astellas Pharma Details
2.2.2 Astellas Pharma Major Business
2.2.3 Astellas Pharma Prostate Cancer Drugs Product and Services
2.2.4 Astellas Pharma Prostate Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Astra Zeneca
2.3.1 Astra Zeneca Details
2.3.2 Astra Zeneca Major Business
2.3.3 Astra Zeneca Prostate Cancer Drugs Product and Services
2.3.4 Astra Zeneca Prostate Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Johnson & Johnson
2.4.1 Johnson & Johnson Details
2.4.2 Johnson & Johnson Major Business
2.4.3 Johnson & Johnson Prostate Cancer Drugs Product and Services
2.4.4 Johnson & Johnson Prostate Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Sanofi
2.5.1 Sanofi Details
2.5.2 Sanofi Major Business
2.5.3 Sanofi Prostate Cancer Drugs Product and Services
2.5.4 Sanofi Prostate Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 GlaxoSmithKline
2.6.1 GlaxoSmithKline Details
2.6.2 GlaxoSmithKline Major Business
2.6.3 GlaxoSmithKline Prostate Cancer Drugs Product and Services
2.6.4 GlaxoSmithKline Prostate Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Merck Group
2.7.1 Merck Group Details
2.7.2 Merck Group Major Business
2.7.3 Merck Group Prostate Cancer Drugs Product and Services
2.7.4 Merck Group Prostate Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Novartis
2.8.1 Novartis Details
2.8.2 Novartis Major Business
2.8.3 Novartis Prostate Cancer Drugs Product and Services
2.8.4 Novartis Prostate Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Amgen
2.9.1 Amgen Details
2.9.2 Amgen Major Business
2.9.3 Amgen Prostate Cancer Drugs Product and Services
2.9.4 Amgen Prostate Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Bayer HealthCare
2.10.1 Bayer HealthCare Details
2.10.2 Bayer HealthCare Major Business
2.10.3 Bayer HealthCare Prostate Cancer Drugs Product and Services
2.10.4 Bayer HealthCare Prostate Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Ferring Pharmaceutical
2.11.1 Ferring Pharmaceutical Details
2.11.2 Ferring Pharmaceutical Major Business
2.11.3 Ferring Pharmaceutical Prostate Cancer Drugs Product and Services
2.11.4 Ferring Pharmaceutical Prostate Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Janssen Pharmaceuticals
2.12.1 Janssen Pharmaceuticals Details
2.12.2 Janssen Pharmaceuticals Major Business
2.12.3 Janssen Pharmaceuticals Prostate Cancer Drugs Product and Services
2.12.4 Janssen Pharmaceuticals Prostate Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Endo Pharmaceuticals
2.13.1 Endo Pharmaceuticals Details
2.13.2 Endo Pharmaceuticals Major Business
2.13.3 Endo Pharmaceuticals Prostate Cancer Drugs Product and Services
2.13.4 Endo Pharmaceuticals Prostate Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 BMS
2.14.1 BMS Details
2.14.2 BMS Major Business
2.14.3 BMS Prostate Cancer Drugs Product and Services
2.14.4 BMS Prostate Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Takeda Pharmaceuticals
2.15.1 Takeda Pharmaceuticals Details
2.15.2 Takeda Pharmaceuticals Major Business
2.15.3 Takeda Pharmaceuticals Prostate Cancer Drugs Product and Services
2.15.4 Takeda Pharmaceuticals Prostate Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16 Northwest Biotherapeutics
2.16.1 Northwest Biotherapeutics Details
2.16.2 Northwest Biotherapeutics Major Business
2.16.3 Northwest Biotherapeutics Prostate Cancer Drugs Product and Services
2.16.4 Northwest Biotherapeutics Prostate Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17 Teva Pharmaceutical
2.17.1 Teva Pharmaceutical Details
2.17.2 Teva Pharmaceutical Major Business
2.17.3 Teva Pharmaceutical Prostate Cancer Drugs Product and Services
2.17.4 Teva Pharmaceutical Prostate Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.18 Boehringer Ingelheim
2.18.1 Boehringer Ingelheim Details
2.18.2 Boehringer Ingelheim Major Business
2.18.3 Boehringer Ingelheim Prostate Cancer Drugs Product and Services
2.18.4 Boehringer Ingelheim Prostate Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.19 Foresee Pharmaceuticals
2.19.1 Foresee Pharmaceuticals Details
2.19.2 Foresee Pharmaceuticals Major Business
2.19.3 Foresee Pharmaceuticals Prostate Cancer Drugs Product and Services
2.19.4 Foresee Pharmaceuticals Prostate Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.20 Tokai Pharmaceuticals
2.20.1 Tokai Pharmaceuticals Details
2.20.2 Tokai Pharmaceuticals Major Business
2.20.3 Tokai Pharmaceuticals Prostate Cancer Drugs Product and Services
2.20.4 Tokai Pharmaceuticals Prostate Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.21 Spectrum Pharmaceuticals
2.21.1 Spectrum Pharmaceuticals Details
2.21.2 Spectrum Pharmaceuticals Major Business
2.21.3 Spectrum Pharmaceuticals Prostate Cancer Drugs Product and Services
2.21.4 Spectrum Pharmaceuticals Prostate Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Prostate Cancer Drugs Breakdown Data by Manufacturer
3.1 Global Prostate Cancer Drugs Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Prostate Cancer Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Prostate Cancer Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Prostate Cancer Drugs Manufacturer Market Share in 2021
3.4.2 Top 6 Prostate Cancer Drugs Manufacturer Market Share in 2021
3.5 Global Prostate Cancer Drugs Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Prostate Cancer Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Prostate Cancer Drugs Market Size by Region
4.1.1 Global Prostate Cancer Drugs Sales in Volume by Region (2017-2028)
4.1.2 Global Prostate Cancer Drugs Revenue by Region (2017-2028)
4.2 North America Prostate Cancer Drugs Revenue (2017-2028)
4.3 Europe Prostate Cancer Drugs Revenue (2017-2028)
4.4 Asia-Pacific Prostate Cancer Drugs Revenue (2017-2028)
4.5 South America Prostate Cancer Drugs Revenue (2017-2028)
4.6 Middle East and Africa Prostate Cancer Drugs Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Prostate Cancer Drugs Sales in Volume by Type (2017-2028)
5.2 Global Prostate Cancer Drugs Revenue by Type (2017-2028)
5.3 Global Prostate Cancer Drugs Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Prostate Cancer Drugs Sales in Volume by Application (2017-2028)
6.2 Global Prostate Cancer Drugs Revenue by Application (2017-2028)
6.3 Global Prostate Cancer Drugs Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Prostate Cancer Drugs Sales by Type (2017-2028)
7.2 North America Prostate Cancer Drugs Sales by Application (2017-2028)
7.3 North America Prostate Cancer Drugs Market Size by Country
7.3.1 North America Prostate Cancer Drugs Sales in Volume by Country (2017-2028)
7.3.2 North America Prostate Cancer Drugs Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Prostate Cancer Drugs Sales by Type (2017-2028)
8.2 Europe Prostate Cancer Drugs Sales by Application (2017-2028)
8.3 Europe Prostate Cancer Drugs Market Size by Country
8.3.1 Europe Prostate Cancer Drugs Sales in Volume by Country (2017-2028)
8.3.2 Europe Prostate Cancer Drugs Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Prostate Cancer Drugs Sales by Type (2017-2028)
9.2 Asia-Pacific Prostate Cancer Drugs Sales by Application (2017-2028)
9.3 Asia-Pacific Prostate Cancer Drugs Market Size by Region
9.3.1 Asia-Pacific Prostate Cancer Drugs Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Prostate Cancer Drugs Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Prostate Cancer Drugs Sales by Type (2017-2028)
10.2 South America Prostate Cancer Drugs Sales by Application (2017-2028)
10.3 South America Prostate Cancer Drugs Market Size by Country
10.3.1 South America Prostate Cancer Drugs Sales in Volume by Country (2017-2028)
10.3.2 South America Prostate Cancer Drugs Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Prostate Cancer Drugs Sales by Type (2017-2028)
11.2 Middle East & Africa Prostate Cancer Drugs Sales by Application (2017-2028)
11.3 Middle East & Africa Prostate Cancer Drugs Market Size by Country
11.3.1 Middle East & Africa Prostate Cancer Drugs Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Prostate Cancer Drugs Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Prostate Cancer Drugs and Key Manufacturers
12.2 Manufacturing Costs Percentage of Prostate Cancer Drugs
12.3 Prostate Cancer Drugs Production Process
12.4 Prostate Cancer Drugs Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Prostate Cancer Drugs Typical Distributors
13.3 Prostate Cancer Drugs Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of Tables
Table 1. Global Prostate Cancer Drugs Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Prostate Cancer Drugs Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. AbbVie Basic Information, Manufacturing Base and Competitors
Table 4. AbbVie Major Business
Table 5. AbbVie Prostate Cancer Drugs Product and Services
Table 6. AbbVie Prostate Cancer Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Astellas Pharma Basic Information, Manufacturing Base and Competitors
Table 8. Astellas Pharma Major Business
Table 9. Astellas Pharma Prostate Cancer Drugs Product and Services
Table 10. Astellas Pharma Prostate Cancer Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Astra Zeneca Basic Information, Manufacturing Base and Competitors
Table 12. Astra Zeneca Major Business
Table 13. Astra Zeneca Prostate Cancer Drugs Product and Services
Table 14. Astra Zeneca Prostate Cancer Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 16. Johnson & Johnson Major Business
Table 17. Johnson & Johnson Prostate Cancer Drugs Product and Services
Table 18. Johnson & Johnson Prostate Cancer Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Sanofi Basic Information, Manufacturing Base and Competitors
Table 20. Sanofi Major Business
Table 21. Sanofi Prostate Cancer Drugs Product and Services
Table 22. Sanofi Prostate Cancer Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 24. GlaxoSmithKline Major Business
Table 25. GlaxoSmithKline Prostate Cancer Drugs Product and Services
Table 26. GlaxoSmithKline Prostate Cancer Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Merck Group Basic Information, Manufacturing Base and Competitors
Table 28. Merck Group Major Business
Table 29. Merck Group Prostate Cancer Drugs Product and Services
Table 30. Merck Group Prostate Cancer Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Novartis Basic Information, Manufacturing Base and Competitors
Table 32. Novartis Major Business
Table 33. Novartis Prostate Cancer Drugs Product and Services
Table 34. Novartis Prostate Cancer Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Amgen Basic Information, Manufacturing Base and Competitors
Table 36. Amgen Major Business
Table 37. Amgen Prostate Cancer Drugs Product and Services
Table 38. Amgen Prostate Cancer Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Bayer HealthCare Basic Information, Manufacturing Base and Competitors
Table 40. Bayer HealthCare Major Business
Table 41. Bayer HealthCare Prostate Cancer Drugs Product and Services
Table 42. Bayer HealthCare Prostate Cancer Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Ferring Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 44. Ferring Pharmaceutical Major Business
Table 45. Ferring Pharmaceutical Prostate Cancer Drugs Product and Services
Table 46. Ferring Pharmaceutical Prostate Cancer Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Janssen Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 48. Janssen Pharmaceuticals Major Business
Table 49. Janssen Pharmaceuticals Prostate Cancer Drugs Product and Services
Table 50. Janssen Pharmaceuticals Prostate Cancer Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Endo Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 52. Endo Pharmaceuticals Major Business
Table 53. Endo Pharmaceuticals Prostate Cancer Drugs Product and Services
Table 54. Endo Pharmaceuticals Prostate Cancer Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. BMS Basic Information, Manufacturing Base and Competitors
Table 56. BMS Major Business
Table 57. BMS Prostate Cancer Drugs Product and Services
Table 58. BMS Prostate Cancer Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Takeda Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 60. Takeda Pharmaceuticals Major Business
Table 61. Takeda Pharmaceuticals Prostate Cancer Drugs Product and Services
Table 62. Takeda Pharmaceuticals Prostate Cancer Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 63. Northwest Biotherapeutics Basic Information, Manufacturing Base and Competitors
Table 64. Northwest Biotherapeutics Major Business
Table 65. Northwest Biotherapeutics Prostate Cancer Drugs Product and Services
Table 66. Northwest Biotherapeutics Prostate Cancer Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 67. Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 68. Teva Pharmaceutical Major Business
Table 69. Teva Pharmaceutical Prostate Cancer Drugs Product and Services
Table 70. Teva Pharmaceutical Prostate Cancer Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 71. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 72. Boehringer Ingelheim Major Business
Table 73. Boehringer Ingelheim Prostate Cancer Drugs Product and Services
Table 74. Boehringer Ingelheim Prostate Cancer Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 75. Foresee Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 76. Foresee Pharmaceuticals Major Business
Table 77. Foresee Pharmaceuticals Prostate Cancer Drugs Product and Services
Table 78. Foresee Pharmaceuticals Prostate Cancer Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 79. Tokai Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 80. Tokai Pharmaceuticals Major Business
Table 81. Tokai Pharmaceuticals Prostate Cancer Drugs Product and Services
Table 82. Tokai Pharmaceuticals Prostate Cancer Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 83. Spectrum Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 84. Spectrum Pharmaceuticals Major Business
Table 85. Spectrum Pharmaceuticals Prostate Cancer Drugs Product and Services
Table 86. Spectrum Pharmaceuticals Prostate Cancer Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 87. Global Prostate Cancer Drugs Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K MT)
Table 88. Global Prostate Cancer Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 89. Market Position of Manufacturers in Prostate Cancer Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 90. Global Prostate Cancer Drugs Production Capacity by Company, (K MT): 2020 VS 2021
Table 91. Head Office and Prostate Cancer Drugs Production Site of Key Manufacturer
Table 92. Prostate Cancer Drugs New Entrant and Capacity Expansion Plans
Table 93. Prostate Cancer Drugs Mergers & Acquisitions in the Past Five Years
Table 94. Global Prostate Cancer Drugs Sales by Region (2017-2022) & (K MT)
Table 95. Global Prostate Cancer Drugs Sales by Region (2023-2028) & (K MT)
Table 96. Global Prostate Cancer Drugs Revenue by Region (2017-2022) & (USD Million)
Table 97. Global Prostate Cancer Drugs Revenue by Region (2023-2028) & (USD Million)
Table 98. Global Prostate Cancer Drugs Sales by Type (2017-2022) & (K MT)
Table 99. Global Prostate Cancer Drugs Sales by Type (2023-2028) & (K MT)
Table 100. Global Prostate Cancer Drugs Revenue by Type (2017-2022) & (USD Million)
Table 101. Global Prostate Cancer Drugs Revenue by Type (2023-2028) & (USD Million)
Table 102. Global Prostate Cancer Drugs Price by Type (2017-2022) & (USD/MT)
Table 103. Global Prostate Cancer Drugs Price by Type (2023-2028) & (USD/MT)
Table 104. Global Prostate Cancer Drugs Sales by Application (2017-2022) & (K MT)
Table 105. Global Prostate Cancer Drugs Sales by Application (2023-2028) & (K MT)
Table 106. Global Prostate Cancer Drugs Revenue by Application (2017-2022) & (USD Million)
Table 107. Global Prostate Cancer Drugs Revenue by Application (2023-2028) & (USD Million)
Table 108. Global Prostate Cancer Drugs Price by Application (2017-2022) & (USD/MT)
Table 109. Global Prostate Cancer Drugs Price by Application (2023-2028) & (USD/MT)
Table 110. North America Prostate Cancer Drugs Sales by Country (2017-2022) & (K MT)
Table 111. North America Prostate Cancer Drugs Sales by Country (2023-2028) & (K MT)
Table 112. North America Prostate Cancer Drugs Revenue by Country (2017-2022) & (USD Million)
Table 113. North America Prostate Cancer Drugs Revenue by Country (2023-2028) & (USD Million)
Table 114. North America Prostate Cancer Drugs Sales by Type (2017-2022) & (K MT)
Table 115. North America Prostate Cancer Drugs Sales by Type (2023-2028) & (K MT)
Table 116. North America Prostate Cancer Drugs Sales by Application (2017-2022) & (K MT)
Table 117. North America Prostate Cancer Drugs Sales by Application (2023-2028) & (K MT)
Table 118. Europe Prostate Cancer Drugs Sales by Country (2017-2022) & (K MT)
Table 119. Europe Prostate Cancer Drugs Sales by Country (2023-2028) & (K MT)
Table 120. Europe Prostate Cancer Drugs Revenue by Country (2017-2022) & (USD Million)
Table 121. Europe Prostate Cancer Drugs Revenue by Country (2023-2028) & (USD Million)
Table 122. Europe Prostate Cancer Drugs Sales by Type (2017-2022) & (K MT)
Table 123. Europe Prostate Cancer Drugs Sales by Type (2023-2028) & (K MT)
Table 124. Europe Prostate Cancer Drugs Sales by Application (2017-2022) & (K MT)
Table 125. Europe Prostate Cancer Drugs Sales by Application (2023-2028) & (K MT)
Table 126. Asia-Pacific Prostate Cancer Drugs Sales by Region (2017-2022) & (K MT)
Table 127. Asia-Pacific Prostate Cancer Drugs Sales by Region (2023-2028) & (K MT)
Table 128. Asia-Pacific Prostate Cancer Drugs Revenue by Region (2017-2022) & (USD Million)
Table 129. Asia-Pacific Prostate Cancer Drugs Revenue by Region (2023-2028) & (USD Million)
Table 130. Asia-Pacific Prostate Cancer Drugs Sales by Type (2017-2022) & (K MT)
Table 131. Asia-Pacific Prostate Cancer Drugs Sales by Type (2023-2028) & (K MT)
Table 132. Asia-Pacific Prostate Cancer Drugs Sales by Application (2017-2022) & (K MT)
Table 133. Asia-Pacific Prostate Cancer Drugs Sales by Application (2023-2028) & (K MT)
Table 134. South America Prostate Cancer Drugs Sales by Country (2017-2022) & (K MT)
Table 135. South America Prostate Cancer Drugs Sales by Country (2023-2028) & (K MT)
Table 136. South America Prostate Cancer Drugs Revenue by Country (2017-2022) & (USD Million)
Table 137. South America Prostate Cancer Drugs Revenue by Country (2023-2028) & (USD Million)
Table 138. South America Prostate Cancer Drugs Sales by Type (2017-2022) & (K MT)
Table 139. South America Prostate Cancer Drugs Sales by Type (2023-2028) & (K MT)
Table 140. South America Prostate Cancer Drugs Sales by Application (2017-2022) & (K MT)
Table 141. South America Prostate Cancer Drugs Sales by Application (2023-2028) & (K MT)
Table 142. Middle East & Africa Prostate Cancer Drugs Sales by Region (2017-2022) & (K MT)
Table 143. Middle East & Africa Prostate Cancer Drugs Sales by Region (2023-2028) & (K MT)
Table 144. Middle East & Africa Prostate Cancer Drugs Revenue by Region (2017-2022) & (USD Million)
Table 145. Middle East & Africa Prostate Cancer Drugs Revenue by Region (2023-2028) & (USD Million)
Table 146. Middle East & Africa Prostate Cancer Drugs Sales by Type (2017-2022) & (K MT)
Table 147. Middle East & Africa Prostate Cancer Drugs Sales by Type (2023-2028) & (K MT)
Table 148. Middle East & Africa Prostate Cancer Drugs Sales by Application (2017-2022) & (K MT)
Table 149. Middle East & Africa Prostate Cancer Drugs Sales by Application (2023-2028) & (K MT)
Table 150. Prostate Cancer Drugs Raw Material
Table 151. Key Manufacturers of Prostate Cancer Drugs Raw Materials
Table 152. Direct Channel Pros & Cons
Table 153. Indirect Channel Pros & Cons
Table 154. Prostate Cancer Drugs Typical Distributors
Table 155. Prostate Cancer Drugs Typical Customers
List of Figures
Figure 1. Prostate Cancer Drugs Picture
Figure 2. Global Prostate Cancer Drugs Revenue Market Share by Type in 2021
Figure 3. Hormonal Therapy
Figure 4. Chemotherapy
Figure 5. Immunotherapy
Figure 6. Targeted Therapy
Figure 7. Global Prostate Cancer Drugs Revenue Market Share by Application in 2021
Figure 8. Clinics
Figure 9. Hospitals
Figure 10. Others
Figure 11. Global Prostate Cancer Drugs Revenue, (USD Million) & (K MT): 2017 & 2021 & 2028
Figure 12. Global Prostate Cancer Drugs Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Prostate Cancer Drugs Sales (2017-2028) & (K MT)
Figure 14. Global Prostate Cancer Drugs Price (2017-2028) & (USD/MT)
Figure 15. Global Prostate Cancer Drugs Production Capacity (2017-2028) & (K MT)
Figure 16. Global Prostate Cancer Drugs Production Capacity by Geographic Region: 2022 VS 2028
Figure 17. Prostate Cancer Drugs Market Drivers
Figure 18. Prostate Cancer Drugs Market Restraints
Figure 19. Prostate Cancer Drugs Market Trends
Figure 20. Global Prostate Cancer Drugs Sales Market Share by Manufacturer in 2021
Figure 21. Global Prostate Cancer Drugs Revenue Market Share by Manufacturer in 2021
Figure 22. Prostate Cancer Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 23. Top 3 Prostate Cancer Drugs Manufacturer (Revenue) Market Share in 2021
Figure 24. Top 6 Prostate Cancer Drugs Manufacturer (Revenue) Market Share in 2021
Figure 25. Global Prostate Cancer Drugs Sales Market Share by Region (2017-2028)
Figure 26. Global Prostate Cancer Drugs Revenue Market Share by Region (2017-2028)
Figure 27. North America Prostate Cancer Drugs Revenue (2017-2028) & (USD Million)
Figure 28. Europe Prostate Cancer Drugs Revenue (2017-2028) & (USD Million)
Figure 29. Asia-Pacific Prostate Cancer Drugs Revenue (2017-2028) & (USD Million)
Figure 30. South America Prostate Cancer Drugs Revenue (2017-2028) & (USD Million)
Figure 31. Middle East & Africa Prostate Cancer Drugs Revenue (2017-2028) & (USD Million)
Figure 32. Global Prostate Cancer Drugs Sales Market Share by Type (2017-2028)
Figure 33. Global Prostate Cancer Drugs Revenue Market Share by Type (2017-2028)
Figure 34. Global Prostate Cancer Drugs Price by Type (2017-2028) & (USD/MT)
Figure 35. Global Prostate Cancer Drugs Sales Market Share by Application (2017-2028)
Figure 36. Global Prostate Cancer Drugs Revenue Market Share by Application (2017-2028)
Figure 37. Global Prostate Cancer Drugs Price by Application (2017-2028) & (USD/MT)
Figure 38. North America Prostate Cancer Drugs Sales Market Share by Type (2017-2028)
Figure 39. North America Prostate Cancer Drugs Sales Market Share by Application (2017-2028)
Figure 40. North America Prostate Cancer Drugs Sales Market Share by Country (2017-2028)
Figure 41. North America Prostate Cancer Drugs Revenue Market Share by Country (2017-2028)
Figure 42. United States Prostate Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Canada Prostate Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Mexico Prostate Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Europe Prostate Cancer Drugs Sales Market Share by Type (2017-2028)
Figure 46. Europe Prostate Cancer Drugs Sales Market Share by Application (2017-2028)
Figure 47. Europe Prostate Cancer Drugs Sales Market Share by Country (2017-2028)
Figure 48. Europe Prostate Cancer Drugs Revenue Market Share by Country (2017-2028)
Figure 49. Germany Prostate Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. France Prostate Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. United Kingdom Prostate Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Russia Prostate Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Italy Prostate Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Asia-Pacific Prostate Cancer Drugs Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Prostate Cancer Drugs Sales Market Share by Application (2017-2028)
Figure 56. Asia-Pacific Prostate Cancer Drugs Sales Market Share by Region (2017-2028)
Figure 57. Asia-Pacific Prostate Cancer Drugs Revenue Market Share by Region (2017-2028)
Figure 58. China Prostate Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Japan Prostate Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Korea Prostate Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. India Prostate Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Southeast Asia Prostate Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Australia Prostate Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. South America Prostate Cancer Drugs Sales Market Share by Type (2017-2028)
Figure 65. South America Prostate Cancer Drugs Sales Market Share by Application (2017-2028)
Figure 66. South America Prostate Cancer Drugs Sales Market Share by Country (2017-2028)
Figure 67. South America Prostate Cancer Drugs Revenue Market Share by Country (2017-2028)
Figure 68. Brazil Prostate Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Argentina Prostate Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Middle East & Africa Prostate Cancer Drugs Sales Market Share by Type (2017-2028)
Figure 71. Middle East & Africa Prostate Cancer Drugs Sales Market Share by Application (2017-2028)
Figure 72. Middle East & Africa Prostate Cancer Drugs Sales Market Share by Region (2017-2028)
Figure 73. Middle East & Africa Prostate Cancer Drugs Revenue Market Share by Region (2017-2028)
Figure 74. Turkey Prostate Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Egypt Prostate Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Saudi Arabia Prostate Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. South Africa Prostate Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Manufacturing Cost Structure Analysis of Prostate Cancer Drugs in 2021
Figure 79. Manufacturing Process Analysis of Prostate Cancer Drugs
Figure 80. Prostate Cancer Drugs Industrial Chain
Figure 81. Sales Channel: Direct Channel vs Indirect Channel
Figure 82. Methodology
Figure 83. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
